277 related articles for article (PubMed ID: 10520978)
1. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.
Bohus MJ; Landwehrmeyer GB; Stiglmayr CE; Limberger MF; Böhme R; Schmahl CG
J Clin Psychiatry; 1999 Sep; 60(9):598-603. PubMed ID: 10520978
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder.
Schmahl C; Kleindienst N; Limberger M; Ludäscher P; Mauchnik J; Deibler P; Brünen S; Hiemke C; Lieb K; Herpertz S; Reicherzer M; Berger M; Bohus M
Int Clin Psychopharmacol; 2012 Jan; 27(1):61-8. PubMed ID: 22002175
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of dissociative symptoms in borderline patients with naltrexone].
Schmahl C; Stiglmayr C; Böhme R; Bohus M
Nervenarzt; 1999 Mar; 70(3):262-4. PubMed ID: 10231814
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
Schmahl C; Bohus M
Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
[No Abstract] [Full Text] [Related]
5. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
Bolm T; Piegler T
Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
[TBL] [Abstract][Full Text] [Related]
6. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder.
Philipsen A; Richter H; Schmahl C; Peters J; Rüsch N; Bohus M; Lieb K
J Clin Psychiatry; 2004 Oct; 65(10):1414-9. PubMed ID: 15491247
[TBL] [Abstract][Full Text] [Related]
7. Borderline personality disorder and dissociation.
Ross CA
J Trauma Dissociation; 2007; 8(1):71-80. PubMed ID: 17409055
[TBL] [Abstract][Full Text] [Related]
8. Dissociative phenomena in women with borderline personality disorder.
Shearer SL
Am J Psychiatry; 1994 Sep; 151(9):1324-8. PubMed ID: 8067488
[TBL] [Abstract][Full Text] [Related]
9. Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder.
Philipsen A; Schmahl C; Lieb K
Pharmacopsychiatry; 2004 Sep; 37(5):196-9. PubMed ID: 15470797
[TBL] [Abstract][Full Text] [Related]
10. Axis I dissociative disorder comorbidity in borderline personality disorder and reports of childhood trauma.
Sar V; Akyuz G; Kugu N; Ozturk E; Ertem-Vehid H
J Clin Psychiatry; 2006 Oct; 67(10):1583-90. PubMed ID: 17107251
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior].
García MC
Vertex; 2020 Apr; XXX(148):1-10. PubMed ID: 33890928
[TBL] [Abstract][Full Text] [Related]
12. [Low dose naltrexone in the treatment of dissociative symptoms].
Pape W; Wöller W
Nervenarzt; 2015 Mar; 86(3):346-51. PubMed ID: 25421416
[TBL] [Abstract][Full Text] [Related]
13. [Contribution of dissociative symptoms to antisocial behavior in a sample of high-school students].
Chabrol H; Saint-Martin C; Sejourné N; Moyano O
Encephale; 2009 Feb; 35(1):52-6. PubMed ID: 19250994
[TBL] [Abstract][Full Text] [Related]
14. Comorbid personality disorders and their impact on severe dissociative experiences in Mexican patients with borderline personality disorder.
Rodríguez-Delgado A; Fresán A; Miranda E; Garza-Villarreal E; Alcalá-Lozano R; Duque-Alarcón X; Balducci T; Arango de Montis I
Nord J Psychiatry; 2019 Nov; 73(8):509-514. PubMed ID: 31453750
[No Abstract] [Full Text] [Related]
15. Comparing the symptoms and mechanisms of "dissociation" in dissociative identity disorder and borderline personality disorder.
Laddis A; Dell PF; Korzekwa M
J Trauma Dissociation; 2017; 18(2):139-173. PubMed ID: 27245196
[TBL] [Abstract][Full Text] [Related]
16. Relationship of dissociation to self-mutilation and childhood abuse in borderline personality disorder.
Brodsky BS; Cloitre M; Dulit RA
Am J Psychiatry; 1995 Dec; 152(12):1788-92. PubMed ID: 8526247
[TBL] [Abstract][Full Text] [Related]
17. [Symptoms of DSM IV borderline personality disorder in a nonclinical population of adolescents: study of a series of 35 patients].
Chabrol H; Chouicha K; Montovany A; Callahan S
Encephale; 2001; 27(2):120-7. PubMed ID: 11407263
[TBL] [Abstract][Full Text] [Related]
18. An open trial of valproate in borderline personality disorder.
Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
[TBL] [Abstract][Full Text] [Related]
19. Childhood emotional abuse and dissociation in patients with conversion symptoms.
Sar V; Islam S; Oztürk E
Psychiatry Clin Neurosci; 2009 Oct; 63(5):670-7. PubMed ID: 19674379
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
Roth AS; Ostroff RB; Hoffman RE
J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
